We are live on ! Find out more
LP

Lexington Partners Portfolio holdings

AUM $134M
1-Year Est. Return 1.93%
This Fund
S&P 500
This Quarter Est. Return
+7.78%
1 Year Est. Return
-1.93%
3 Year Est. Return
+1.27%
5 Year Est. Return
-12.6%
10 Year Est. Return
AUM
$235M
AUM Growth
+$44.2M
Cap. Flow
+$45.1M
Cap. Flow %
19.16%
Top 10 Hldgs %
100%
Holding
7
New
2
Increased
Reduced
1
Closed
1

Top Buys

Rank Stock Value
1
DNB
Dun & Bradstreet
DNB
+$51M
2
DNUT icon
Krispy Kreme
DNUT
+$16M

Top Sells

Rank Stock Value
1
COMP icon
Compass
COMP
+$21.4M
2
SNDX icon
Syndax Pharmaceuticals
SNDX
+$545K

Sector Composition

Rank Sector Weight
1 Consumer Staples 55.78%
2 Financials 23.34%
3 Technology 13.33%
4 Real Estate 7.54%
5 Healthcare 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KDP icon
1
Keurig Dr Pepper
KDP
$42.3B
$111M 47.04%
3,001,248
DNB
2
DELISTED
Dun & Bradstreet
DNB
$54.9M 23.34%
+2,679,211
New +$51M
DNUT icon
3
Krispy Kreme
DNUT
$569M
$20.6M 8.75%
+1,087,353
New +$16M
COMP icon
4
Compass
COMP
$10.2B
$17.7M 7.54%
1,951,155
-1,951,155
-50% -$21.4M
SWI
5
DELISTED
SolarWinds Corporation Common Stock
SWI
$17.6M 7.48%
1,239,867
NABL icon
6
N-able
NABL
$695M
$13.8M 5.85%
1,239,867
SNDX icon
7
Syndax Pharmaceuticals
SNDX
$1.7B
-28,499
Closed -$545K

Similar funds

Lexington Partners's Q4 2021 Portfolio in Review

As of Q4 2021, Lexington Partners held 7 positions worth $235M, up 23% from $191M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Lexington Partners deployed $45.1M of net new capital in Q4 2021, opening 2 new positions. Its largest new stake was Dun & Bradstreet: 2,679,211 shares worth $54.9M.

By sector, the portfolio is most concentrated in Consumer Staples at 56% of assets, up from 54% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Compass, an estimated $21.4M trimmed.

  • Lexington Partners's largest Q4 2021 buy was Dun & Bradstreet: 2,679,211 shares worth $54.9M.
  • Lexington Partners's biggest Q4 2021 reduction was Compass, cutting an estimated $21.4M.
  • Lexington Partners fully exited Syndax Pharmaceuticals in Q4 2021, selling an estimated $545K.
  • Lexington Partners's ten largest holdings make up 100% of its $235M portfolio in Q4 2021.
  • Lexington Partners opened 2 new positions and closed 1 in Q4 2021.
  • Lexington Partners's portfolio value rose 23% quarter-over-quarter to $235M.

Based on Lexington Partners's 13F filing for Q4 2021, filed 11 Feb 2022.